Related Experiment Videos
[A familial case of prostate cancer in three brothers]
Abstract:
We treated three brothers for prostate cancer. The first brother developed the disease of poorly differentiated adenocarcinoma at the age of 76, and was treated with endocrine therapy but died of recurrent cancer at age 80. The second brother was diagnosed poorly differentiated adenocarcinoma at age 75, and he is alive at age 80 without recurrence after endocrine therapy. The third brother developed moderately differentiated adenocarcinoma at age 58, and was treated with endocrine therapy but died of recurrent cancer at age 73. We have seen few familial cases of prostate cancer. The first such case is reported here in Japan. Eleven similar cases of familial prostate cancer involving three or more brothers have been reported in the Western literature.
Insights
This study reports a rare familial prostate cancer case in Japan involving three brothers. Familial prostate cancer highlights the need for genetic research into the disease.
Area of Science:
- Oncology
- Genetics
- Epidemiology
Background:
- Prostate cancer is a significant health concern globally.
- Familial clustering of prostate cancer suggests a potential genetic predisposition.
- Understanding familial prostate cancer is crucial for risk assessment and targeted therapies.
Observation:
- Three brothers were diagnosed with prostate cancer, with varying degrees of differentiation and outcomes.
- The first brother had poorly differentiated adenocarcinoma, treated with endocrine therapy, and experienced recurrence.
- The second brother also had poorly differentiated adenocarcinoma, responding well to endocrine therapy without recurrence.
- The third brother presented with moderately differentiated adenocarcinoma, treated with endocrine therapy, but succumbed to recurrence.
Findings:
- This case represents the first reported instance of familial prostate cancer involving three brothers in Japan.
- The observed outcomes highlight variability in disease progression and treatment response within a single family.
- Eleven similar familial prostate cancer cases involving three or more brothers have been documented in Western literature.
Implications:
- This case underscores the importance of considering family history in prostate cancer diagnosis and management.
- Further genetic research is warranted to identify specific genes or mutations contributing to familial prostate cancer.
- Early detection and personalized treatment strategies may improve outcomes for families with a history of prostate cancer.